title: The role of bone morphogenetic proteins in the differentiation of the ventral optic cup.
abstract: The ventral region of the chick embryo optic cup undergoes a complex process of differentiation leading to the formation of four different structures: the neural retina, the retinal pigment epithelium (RPE), the optic disk/optic stalk, and the pecten oculi. Signaling molecules such as retinoic acid and sonic hedgehog have been implicated in the regulation of these phenomena. We have now investigated whether the bone morphogenetic proteins (BMPs) also regulate ventral optic cup development. Loss-of-function experiments were carried out in chick embryos in ovo, by intraocular overexpression of noggin, a protein that binds several BMPs and prevents their interactions with their cognate cell surface receptors. At optic vesicle stages of development, this treatment resulted in microphthalmia with concomitant disruption of the developing neural retina, RPE and lens. At optic cup stages, however, noggin overexpression caused colobomas, pecten agenesis, replacement of the ventral RPE by neuroepithelium-like tissue, and ectopic expression of optic stalk markers in the region of the ventral retina and RPE. This was frequently accompanied by abnormal growth of ganglion cell axons, which failed to enter the optic nerve. The data suggest that endogenous BMPs have significant effects on the development of ventral optic cup structures.
authors.affiliation: The Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
authors.forename: Ruben
authors.initials: R
authors.lastname: Adler
authors.forename: Teri L
authors.initials: TL
authors.lastname: Belecky-Adams
mesh_terms: D000818:Animals; D019485:Bone Morphogenetic Proteins / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism*; D015820:Cadherins / Q000378:metabolism; D002352:Carrier Proteins; D002454:Cell Differentiation; D002642:Chick Embryo; D005123:Eye / Q000196:embryology*; D005124:Eye Abnormalities / Q000235:genetics; D051524:Fibroblast Growth Factor 8; D005346:Fibroblast Growth Factors / Q000235:genetics / Q000378:metabolism; D018507:Gene Expression Regulation, Developmental; D053823:Hedgehog Proteins; D007797:Laminin / Q000235:genetics / Q000378:metabolism; D008845:Microinjections; D008850:Microphthalmos / Q000235:genetics; D009414:Nerve Growth Factors / Q000235:genetics / Q000378:metabolism; D000075388:Netrin-1; D009900:Optic Nerve / Q000196:embryology / Q000378:metabolism / Q000473:pathology; D011506:Proteins / Q000235:genetics* / Q000378:metabolism; D012160:Retina / Q000196:embryology; D012190:Retroviridae / Q000235:genetics; D015534:Trans-Activators / Q000235:genetics / Q000378:metabolism; D025521:Tumor Suppressor Proteins; D000099176:Noggin Protein
chemical_list: D019485:Bone Morphogenetic Proteins; D015820:Cadherins; D002352:Carrier Proteins; D051524:Fibroblast Growth Factor 8; D005346:Fibroblast Growth Factors; D053823:Hedgehog Proteins; D007797:Laminin; D009414:Nerve Growth Factors; D000075388:Netrin-1; D011506:Proteins; D015534:Trans-Activators; D025521:Tumor Suppressor Proteins; D000099176:Noggin Protein; C083970:R-cadherin